What happened when cannabis was legalised in the US?
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “What happened when cannabis was legalised in the US?” inside PodZeus.
This episode of The Lancet Voice explores the profound societal, health, and policy shifts resulting from the legalization of cannabis in the United States over the past two decades. Hosted by Niall Boyce and Miriam, with expert insights from Professor Deborah Hassan of Columbia University, the discussion traces the evolution from California's 1996 medical cannabis legalization to the current landscape where over 80% of U.S. states permit medical use and about 25 allow recreational access. Despite federal prohibition, state-level action has driven a cultural and commercial transformation, with cannabis now widely available in licensed dispensaries and increasingly normalized in public life—particularly in cities like New York. However, this shift has brought significant public health concerns, including rising rates of cannabis use disorder, increased risk of psychosis among vulnerable populations, and emerging conditions like cannabinoid hyperemesis syndrome. The episode also highlights critical gaps in regulation, such as the absence of standardized labeling, FDA oversight, and reliable roadside testing for impaired driving. While some benefits are noted—such as reduced opioid use and fewer cannabis-related arrests—the overall picture is complex, with evidence suggesting that legalization has amplified both access and risk, especially among adults with psychiatric or chronic pain conditions. The conversation underscores the urgent need for better research, particularly through rescheduling cannabis to allow more rigorous clinical trials. Professor Hassan reflects on her own journey from initial support for legalization to a more cautious stance, driven by data showing real harms. The episode concludes with a call for balanced, evidence-based public education and healthcare provider guidance, emphasizing that the U.S. is conducting a massive, real-world social experiment with long-term implications. With national surveys continuing to provide vital data, the hope is that future analysis will offer clearer insights into the true balance of harms and benefits, even as political and cultural divides persist across states.
Cannabis legalization in the U.S. has expanded rapidly at the state level, with 40+ states allowing medical use and 25+ permitting recreational access, despite federal illegality.
Rising cannabis use and cannabis use disorder rates—especially in adults and those with psychiatric or chronic pain conditions—suggest a public health challenge linked to increased availability.
High-potency cannabis products, especially via vaping and dabbing, are more potent than historical strains and may increase risks of psychosis and other harms.
Lack of standardized labeling, FDA oversight, and roadside testing for cannabis impairment undermines consumer safety and regulatory effectiveness.
While cannabis may reduce opioid use and lower arrests for low-level possession, these benefits must be weighed against growing evidence of mental health risks and dependency.
…and 3 more takeaways available in PodZeus
Introduction and Context: The Changing Legal Landscape of Cannabis in the U.S.
The episode opens with hosts Niall Boyce and Miriam introducing the topic of cannabis legalization in the U.S., setting the stage for a deep dive into its social, legal, and health implications. Niall shares his personal evolution from supporting legalization to recognizing its complexities, while Miriam provides a firsthand account of cannabis normalization in New York City. The discussion is framed as a major societal experiment unfolding across the country.
From Medical to Recreational: The Evolution of State-Level Legalization
“While it's remained illegal at the federal level, the states have not waited around for the feds. And because of various disjunctures between federal and state policy, the states have really been able to have the sway in terms of legalization of cannabis in the U.S.”
Public Health Consequences: Rising Use, Disorder, and Mental Health Risks
“People that have that type of a family background should really be advised to think very carefully about whether they want to take the risk of using cannabis to have something like that happen to them.”
Regulatory Gaps and the Commercialization of Cannabis
“You have an industry that really wants to emphasize the benefits and not draw people's attention to the risks. And so I really don't know that there is much attention drawn to that right now.”
The Future of Research, Policy, and Public Understanding
“I think that's really gotten in the way in some ways of having research that can be done where you have, you know, you can have measurable quantities of cannabinoids administered to people in placebo-controlled situations...”
“People that have that type of a family background should really be advised to think very carefully about whether they want to take the risk of using cannabis to have something like that happen to them.”
“While it's remained illegal at the federal level, the states have not waited around for the feds. And because of various disjunctures between federal and state policy, the states have really been able to have the sway in terms of legalization of cannabis in the U.S.”
“I think that's really gotten in the way in some ways of having research that can be done where you have, you know, you can have measurable quantities of cannabinoids administered to people in placebo-controlled situations...”
Hosts
Guest
Professor Deborah Hassan
person
Miriam
person
New York
place
Niall Boyce
person
American Psychiatric Association
organization
The Lancet
organization
California
place
FDA
organization
Veterans Administration
organization
Columbia University
organization
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “What happened when cannabis was legalised in the US?” inside PodZeus.
Start discovering podcast insights today
Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.
No credit card required • 7-day trial • Cancel anytime
